N. Giallombardo

A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).

M. Regan, D. McDermott, R. Joyce, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer

P. Richardson, D. Kufe, D. McDermott, 2000, Bone Marrow Transplantation.

Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation

N. Munshi, J. Laubach, P. Richardson, 2012 .

Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.

M. Regan, D. McDermott, R. Joyce, 2001, European journal of haematology. Supplementum.